Company intelligence / Profile preview

Ciliatech

Chavanod, Auvergne-Rhône-Alpes, Francecilia.tech ↗

Ownership: Private
Development stage: Phase 3

Overview

Ciliatech’s Intercil® Uveal Spacer has demonstrated robust intraocular pressure lowering and a high safety profile in multiple clinical trials. At three years, data from the SAFARI studies show a mean IOP reduction of approximately 33% from baseline, with up to 68% of patients medication-free at three years. No new safety issues or need for additional surgery were reported over this period. The device avoids both anterior chamber entry and bleb formation, offering a novel approach to surgical glaucoma management. Regulatory submissions are planned.

Therapeutic areas: Ophthalmology
Modalities: DeviceMedical device (implant)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Intercil

Phase 3

Indications: Glaucoma, Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma

Partnerships

World-class panel of global key opinion leaders/professors/doctors of ophthalmology guiding product development strategy

Beyond the preview

Go deeper on Ciliatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciliatech.

Explore the full profile